Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Novartis Self-Medication U.S. operations to be headed by Sandoz' Fred Huser.

This article was originally published in The Tan Sheet

Executive Summary

NOVARTIS U.S. SELF-MEDICATION BUSINESS TO BE HEADED BY FRED HUSER, current president of Sandoz' U.S. consumer pharmaceuticals business, Ciba-Geigy announced May 7. Huser will report to Novartis worldwide self-medication head Roland Jeannet, who currently leads Ciba's worldwide OTC division. The companies, which announced their intention to merge in early March ("The Tan Sheet" March 11, p. 1), plan to announce VP-level positions in the new structure in June.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS085382

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel